Clinical Trial Update: Multiple Donor Treg DLI for Severe Refractory Chronic GVHD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating multiple donor regulatory T cell (Treg) donor lymphocyte infusion for severe refractory chronic graft-versus-host disease has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Multiple donor regulatory T cell (Treg) donor lymphocyte infusion

Snippet

Sponsor: Mario Arpinati | Conditions: Chronic Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED